A Randomized Study of Lung Cancer Screening with Spiral Computed Tomography
The mortality benefit from lung cancer screening by LDCT might be far smaller than anticipated.
The mortality benefit from lung cancer screening by LDCT might be far smaller than anticipated.
In patients with advanced hepatocellular carcinoma, median survival and the time to radiologic progression were nearly 3 months longer for patients treated with sorafenib than f...
Ceritinib was highly active in patients with advanced, ALK-rearranged NSCLC, including those who had had disease progression during crizotinib treatment, regardless of the prese...
ClinicalTrials.gov Identifier: NCT01658878.
h-index: Number of publications with at least h citations each.